The global colposcopes market is expected to reach USD 345.4 Million by 2028, according to a new report by Reports and Data. Colposcopes are generally used to scrutinize brightened, magnified view of vagina, cervix, and vulva for any sign of disease.
Growing use of colposcopes in gynecology diagnosis is one of the significant factors influencing market growth. Cervical cancer is one most common causes of cancer in women, with over 500,000 new cases taking place per year across the globe. Cervical cancer is generally diagnosed between the age range of 35 years and 44 years. Approximately 15.0% of women aged above 65 years are diagnosed with cervical cancer. In 2019, over 13,000 women in the U.S. were diagnosed with invasive cervical cancer. Occurrence rates for the disease fell by over 50% between 1975 and 2015 owing partially to an increase in screening, which can detect cervical changes before becoming cancerous. Survival rates in cases of cervical cancer depend on several factors, such as the diagnosis stage of cervical cancer. When diagnosed at an early stage, the survival rate is around 92.0% for women having invasive cervical cancer is 92%.
Market Overview:
The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
Some key highlights of the report:
- By product type, digital colposcopes are estimated to witness a faster growth rate of 7.5% in the forecast period. Digital image processing methods allow contrast improvement of properties, including abnormal vasculature and white epithelium, and in this way are assisting colposcopists to recognize and grade a lesion.
- By portability, stationary colposcopes dominated the market in 2018 and is expected to grow at a rate of 5.8% in the forecast period. The market dominance of stationary colposcopes is owing to their availability at lower prices, thus creating an increased demand for this type in organizations with budget constraints.
- By applications, pelvic application accounted for a larger market share in 2018 and is expected to grow at a rate of 6.3% in the forecast period.
- By end-users, hospitals dominated the market in 2018. The factors including well-resourced diagnostic rooms, higher purchasing power, existence of highly skilled healthcare professionals, and improved health coverage for hospital-based healthcare services from several private and group insurance plans, among others, are responsible for the high market share of hospitals.
- Europe held the second-largest market share in 2018 and is expected to observe a growth rate of 6.0% in the forecast period.
Key Players covered in this report are
Olympus, Philips Healthcare, Atmos, Karl Kaps GmbH Co. KG, Carl Zeiss, McKesson, Danaher, DYSIS Medical, Seiler Instrument Inc., and Alliton, among others.
Product Type Outlook (Revenue, USD Million; 2018-2028)
- Optical Colposcopes
- Digital Colposcopes
Portability Outlook (Revenue, USD Million; 2018-2028)
- Stationary
- Handheld
Applications Outlook (Revenue, USD Million; 2018-2028)
- Oral
- Pelvic
End-Users Outlook (Revenue, USD Million; 2018-2028)
- Hospitals Clinics
- Diagnostic Centers
Key Regional Markets Studied in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2389
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
